Skip to content

Avanos Medical AVNS Other accrued liabilities

Other accrued liabilities at other companies

Cardinal Health logo
Cardinal HealthCAH
$3.48B+5.4%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
Novanta logo
NovantaNOVT
Globus Medical logo
Globus MedicalGMED
Enovis logo
EnovisENOV

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's other accrued liabilities?
Avanos Medical (AVNS) reported other accrued liabilities of $18.3M in Q1 2026.
How has Avanos Medical's other accrued liabilities changed year-over-year?
Avanos Medical's other accrued liabilities increased by 39.7% year-over-year, from $13.1M to $18.3M.
What is the long-term trend for Avanos Medical's other accrued liabilities?
Over 5 years (2020 to 2025), Avanos Medical's other accrued liabilities has grown at a 2.0% compound annual growth rate (CAGR), from $22M to $24.3M.